Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Experiences of long-term treatment with remoxipride: efficacy and tolerability.

Wålinder J, Holm AC.

Acta Psychiatr Scand Suppl. 1990;358:158-63.

PMID:
1978477
2.

Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.

Freeman HL.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S11-7. Review.

PMID:
9218163
3.

[Remoxipride, a selective antagonist of dopamine D2 receptors, in the treatment of delusional psychoses].

Lewander T, Westerberg SE, Ogren SO, Von Bahr C, Köhler C.

Encephale. 1990 Mar-Apr;16(2):153-7. Review. French.

PMID:
1972054
4.

Treatment programme and long-term outcome in chronic schizophrenia.

Kane JM.

Acta Psychiatr Scand Suppl. 1990;358:151-7. Review.

PMID:
1978476
5.

[Treatment of negative symptoms in schizophrenia by amisulpride. Review of the literature].

Pélissolo A, Krebs MO, Olié JP.

Encephale. 1996 May-Jun;22(3):215-9. Review. French.

PMID:
8767050
6.

Remoxipride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in schizophrenia.

Wadworth AN, Heel RC.

Drugs. 1990 Dec;40(6):863-79. Review. Erratum in: Drugs 1991 Apr;41(4):532.

PMID:
1981869
7.

Implications for the pharmacotherapy of schizophrenia.

[No authors listed]

Rep Group Adv Psychiatry. 1992;(134):35-58. Review. No abstract available.

PMID:
1348372
8.

A rational approach to employing high plasma levels of antipsychotics for violence associated with schizophrenia: case vignettes.

Meyer JM.

CNS Spectr. 2014 Oct;19(5):432-8. doi: 10.1017/S1092852914000236. Epub 2014 May 27. Review.

PMID:
24865765

Supplemental Content

Support Center